Stefan Fröhling

Stefan Fröhling is the head of the Department of Translational Medical Oncology at the National Center for Tumor Diseases (NCT) in Heidelberg, Germany. He is recognized for his work in the field of precision medicine, particularly in oncology, where he has contributed to significant advancements in the diagnosis and treatment of cancer through genetic methods. Fröhling emphasizes the importance of personalized approaches to cancer treatment, moving away from one-size-fits-all strategies to more tailored therapies based on individual genetic profiles.